The Analytical Development Team at CTMC is responsible for the design, execution, and optimization of analytical methods to evaluate the quality and efficacy of cell therapies. This team collaborates closely with manufacturing and research teams to ensure compliance with regulatory standards and to support the development of innovative therapeutic solutions. They utilize advanced technologies to analyze viral vectors and other biologics, ensuring that all cell therapies produced meet stringent safety and effectiveness criteria for cancer patients.
View all